| __timestamp | Soleno Therapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 382096000000 |
| Thursday, January 1, 2015 | 4536244 | 345927000000 |
| Friday, January 1, 2016 | 5184803 | 312303000000 |
| Sunday, January 1, 2017 | 3068742 | 325441000000 |
| Monday, January 1, 2018 | 7178000 | 368298000000 |
| Tuesday, January 1, 2019 | 16267000 | 492381000000 |
| Wednesday, January 1, 2020 | 23191000 | 455833000000 |
| Friday, January 1, 2021 | 21453000 | 526087000000 |
| Saturday, January 1, 2022 | 15265000 | 633325000000 |
| Sunday, January 1, 2023 | 25189000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Infusing magic into the data realm
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Takeda's R&D expenses have surged by approximately 91%, reaching a staggering $730 billion in 2023. This reflects Takeda's robust strategy to maintain its competitive edge in the global market. In contrast, Soleno Therapeutics, a smaller player, has increased its R&D spending by over 1,000% during the same period, peaking at $25 million in 2023. This growth underscores Soleno's aggressive push to innovate and expand its niche offerings. While Takeda's vast resources allow for substantial investment, Soleno's rapid growth in R&D spending highlights its strategic focus on innovation despite its smaller scale.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.